As we age our immune system weakens leading to increased vulnerability to various diseases including COVID-19. This has proven to be a particular challenge for vaccine efficacy among the elderly population who often require higher doses or more frequent vaccinations to achieve immunization. However a group of researchers from the University of Cambridge has now identified a potential solution to this problem that involves rejuvenating the immune cells of older individuals.
The study published in the journal Cell Reports found that a protein known as SIRT1 plays a crucial role in maintaining the function of immune cells called CD8+ T cells which are essential for the body to defend itself against infections and illnesses. SIRT1 levels decline as we age compromising the ability of CD8+ T cells to function optimally. However the team discovered that by boosting levels of SIRT1 in older mice they were able to reverse this decline and restore the immune cells' functionality.
The researchers then went on to investigate whether the same approach could be used to improve vaccine efficacy in elderly mice. They found that by first treating the mice with a drug that increased SIRT1 levels the mice were then able to mount a more robust immune response to a subsequent influenza vaccination. This suggests that rejuvenating immune cells in older individuals may be a viable strategy to boost vaccine efficacy and protect against infectious diseases.
The team is now planning to conduct further studies to determine whether this approach could work in humans and if so to develop potential therapies based on these findings. The implications of this research go beyond just protecting against infectious diseases as CD8+ T cells are also vital in fighting cancer and other illnesses.
In light of the ongoing COVID-19 pandemic this research has particular significance. As governments and healthcare systems around the world race to vaccinate their populations finding ways to improve vaccine efficacy especially among vulnerable groups like the elderly has never been more critical.
